Sequana Medical N.V.
SEQUA.BR · BRU
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | €106 | €712 | €923 | €371 |
| % Growth | -85.1% | -22.8% | 149% | – |
| Cost of Goods Sold | €26 | €164 | €205 | €77 |
| Gross Profit | -€2,218 | €548 | €718 | €294 |
| % Margin | -2,092.5% | 77% | 77.8% | 79.3% |
| R&D Expenses | €1,683 | €5,277 | €7,707 | €6,140 |
| G&A Expenses | €6,313 | €6,943 | €6,687 | €5,098 |
| SG&A Expenses | €16,488 | €20,322 | €17,137 | €14,147 |
| Sales & Mktg Exp. | €1,058 | €1,799 | €2,240 | €2,079 |
| Other Operating Expenses | €615 | €0 | €4,499 | €3,825 |
| Operating Expenses | €18,786 | €25,599 | €29,343 | €24,112 |
| Operating Income | -€18,706 | -€29,491 | -€28,094 | -€22,649 |
| % Margin | -17,647.2% | -4,141.1% | -3,044.9% | -6,113.2% |
| Other Income/Exp. Net | -€25,667 | -€2,606 | -€2,282 | -€608 |
| Pre-Tax Income | -€44,373 | -€32,098 | -€30,376 | -€23,222 |
| Tax Expense | €280 | €466 | €387 | €393 |
| Net Income | -€44,654 | -€32,564 | -€30,763 | -€23,615 |
| % Margin | -42,126.4% | -4,572.4% | -3,334.1% | -6,373.8% |
| EPS | -1.22 | -1.22 | -1.35 | -1.3 |
| % Growth | 0% | 9.6% | -3.8% | – |
| EPS Diluted | -1.22 | -1.22 | -1.35 | -1.3 |
| Weighted Avg Shares Out | 36,602 | 26,774 | 22,770 | 18,213 |
| Weighted Avg Shares Out Dil | 36,602 | 26,774 | 22,770 | 18,213 |
| Supplemental Information | – | – | – | – |
| Interest Income | €213 | €1,052 | €0 | €0 |
| Interest Expense | €26,363 | €4,288 | €880 | €573 |
| Depreciation & Amortization | €615 | €355 | €812 | €409 |
| EBITDA | -€17,394 | -€29,137 | -€29,194 | -€22,241 |
| % Margin | -16,409.4% | -4,091.3% | -3,164% | -6,002.9% |